What's Going On With Lantheus Stock Monday? - Lantheus Holdings (NASDAQ:LNTH)

Lantheus receives FDA Complete Response Letter for LNTH-2501. William Blair pushes Octevy sales outlook back by one year.

Raccontata dabenzinga.com